NCT03942575

Brief Summary

To evaluate the risk of postoperative wound complications following the use of Avelle negative pressure wound therapy in patients undergoing mastectomy and flap fixation, which might serve as a basis for a randomized controlled trial

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 8, 2019

Completed
23 days until next milestone

Study Start

First participant enrolled

May 31, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

July 2, 2020

Status Verified

July 1, 2020

Enrollment Period

1 year

First QC Date

May 6, 2019

Last Update Submit

July 1, 2020

Conditions

Keywords

Negative pressure wound therapy

Outcome Measures

Primary Outcomes (1)

  • Number of patients with post-operative wound complications

    Number of patients with post-operative wound complications defined as follows: 1. Surgical site infection (SSI) is defined as redness, pain, heat or swelling at the site of the incision or by the drainage of pus. Infection rate will be measured by A) the need for antibiotics, B) seroma aspiration due to infection or C) surgical drainage during the first three postoperative months. 2. Wound necrosis. Defined as a wound with necrotic tissue that consists of an accumulation of dead cells, tissue and cellular debris and often requires debridement. 3. Wound dehiscence or breakdown defined as a wound that ruptures along a surgical incision and the edges of the wound no longer align.

    During the first three postoperative months

Secondary Outcomes (2)

  • Number of unplanned visits to the ER or breast cancer clinic

    During the first three postoperative months

  • Number of patients with clinically significant seroma

    During the first three postoperative months

Study Arms (2)

No negative pressure wound therapy

NO INTERVENTION

Historical cohort: patients who underwent mastectomy with flap fixation using tissue glue and sutures and closed suction drainage and where negative wound pressure therapy has been omitted

Negative pressure wound therapy

EXPERIMENTAL

Prospective cohort: patients who underwent mastectomy with flap fixation using tissue glue and sutures and closed suction drainage with negative wound pressure therapy

Device: Negative pressure wound therapy

Interventions

Wound dressing with negative pressure on closed incisions

Negative pressure wound therapy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older than 18 years
  • Female sex
  • Indication for mastectomy or modified radical mastectomy

You may not qualify if:

  • Patients undergoing breast conserving therapy
  • Patients undergoing direct breast reconstruction
  • Unable to comprehend implications and extent of study and sign for informed consent
  • Participation in other study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zuyderland Medisch Centrum

Sittard, Limburg, 6162 BG, Netherlands

Location

Related Publications (1)

  • De Rooij L, van Kuijk SMJ, van Haaren ERM, Janssen A, Vissers YLJ, Beets GL, van Bastelaar J. Negative pressure wound therapy does not decrease postoperative wound complications in patients undergoing mastectomy and flap fixation. Sci Rep. 2021 May 5;11(1):9620. doi: 10.1038/s41598-021-89036-3.

MeSH Terms

Conditions

Breast NeoplasmsWound Infection

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesInfections

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: A prospective cohort will be compared to a historical control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Surgeon, Principal Investigator, MD, PhD

Study Record Dates

First Submitted

May 6, 2019

First Posted

May 8, 2019

Study Start

May 31, 2019

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

July 2, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations